Accordingly, higher mRNA expression of BRD9 was also correlated with shorter OS and DFS in HCC patients and was an independent prognostic marker for poorer DFS of HCC patients, suggesting BRD9 played an oncogenic role in HCC. The gene discussed is BRD9; the disease is hepatocellular carcinoma.